北京天智航医疗科技股份有限公司股东减持股份结果公告

Core Viewpoint - The announcement details the completion of a share reduction plan by major shareholders of Beijing Tianzhihang Medical Technology Co., Ltd, specifically the Advanced Manufacturing Industry Investment Fund and the Beijing-Tianjin-Hebei Industry Collaborative Development Investment Fund, both of which are acting in concert. Group 1: Major Shareholder Holdings - Before the reduction plan, the Advanced Manufacturing Fund held 19,308,206 shares, accounting for 4.23% of the total share capital of Tianzhihang. The Beijing-Tianjin-Hebei Fund held 19,310,707 shares, also representing 4.23% of the total share capital. Both funds hold unrestricted tradable shares and are considered concerted actors [1][2]. Group 2: Implementation Results of the Reduction Plan - As of February 2, 2026, the reduction plan was completed. The Advanced Manufacturing Fund reduced its holdings by 2,279,960 shares through centralized bidding, representing 0.50% of the total share capital, and by 4,559,920 shares through block trading, representing 1.00% of the total share capital. The Beijing-Tianjin-Hebei Fund similarly reduced its holdings by 2,279,960 shares through centralized bidding and by 4,559,920 shares through block trading, each also representing 0.50% and 1.00% of the total share capital, respectively [2][4]. Group 3: Compliance and Confirmation - The reduction plan was executed in accordance with relevant laws and regulations, and the actual reduction was consistent with the previously disclosed plan. The plan was fully implemented within the designated time frame, and there were no violations of the reduction plan or other commitments [4][5].